Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

EGFR inhibitors can cause unusual localized hair growth.

The symposium concluded that environmental factors significantly contribute to skin aging.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

SOX4 is crucial for the development of melanoma.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Skin's epithelial stem cells are crucial for repair and maintenance, and understanding them could improve treatments for skin problems.

miR-200c-3p could help diagnose and treat alopecia areata.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Skin reactions from cancer treatments might predict how well the treatments work.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.